{
    "2018-09-04": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Pfizer Prices $5bln Debt Offering",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Debt",
                        "Offering"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Mylan Suffers Several Setbacks: What's in Store in 2H18?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Setbacks",
                        "2H18"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-15",
                "original_text": "Better Buy: Pfizer Inc. vs. Eli Lilly and Company",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "Comparison"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "TREASURIES-Yields rise as investors prepare for corporate debt supply",
                "features": {
                    "keywords": [
                        "Yields",
                        "Rise",
                        "Corporate Debt"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-01",
                "original_text": "Mylan Suffers Several Setbacks: What's in Store in 2H18?",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Setbacks",
                        "2H18"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-15",
                "original_text": "Pfizer says getting ready for Brexit will cost $100m",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Brexit",
                        "Cost"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-20",
                "original_text": "Pfizer Estimates Brexit Costs at $100 Million as Talks Drag",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Brexit",
                        "Costs"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-06-25",
                "original_text": "Pfizer Estimates Brexit Costs at $100 Million as Talks Drag On",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Brexit",
                        "Talks"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}